Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Elliott

Showing results (41-50 of 68) with videos related to

Pageof 7
Sort By:
Journal of Traumatic Stress|July 16, 2004
A concise measure of anger in combat-related posttraumatic stress disorderDavid Forbes, Graeme Hawthorne, Peter Elliott, et al.
Journal of Traumatic Stress|January 2, 2007
Is mixed-handedness a marker of treatment response in posttraumatic stress disorder?: a pilot studyDavid Forbes, Jessica Carty, Peter Elliott, et al.
European Journal of Preventive Cardiology|June 5, 2013
Red flags for persistent or worsening anxiety and depression after an acute cardiac event: a 6-month longitudinal study in regional and rural AustraliaBarbara Murphy, Deborah Ludeman, Peter Elliott, et al.
Journal of Cardiopulmonary Rehabilitation and Prevention|March 13, 2013
Predicting mortality 12 years after an acute cardiac event: comparison between inhospital and 2-month assessment of depressive symptoms in womenBarbara Murphy, Michelle Rogerson, Marian Worcester, et al.
British Journal of Clinical Pharmacology|May 24, 2012
Pharmacokinetics and tolerability of SRT2104, a first-in-class small molecule activator of SIRT1, after single and repeated oral administration in manEthan Hoffmann, Jeff Wald, Siva Lavu, et al.
Nano Letters|August 19, 2021
Spin/Valley Coupled Dynamics of Electrons and Holes at the MoS<sub>2</sub>-MoSe<sub>2</sub> InterfaceAbhijeet Kumar, Denis Yagodkin, Nele Stetzuhn, et al.
Journal of Affective Disorders|February 5, 2013
A trajectory-based approach to understand the factors associated with persistent depressive symptoms in primary careJane Gunn, Peter Elliott, Konstancja Densley, et al.
British Journal of Haematology|December 5, 2012
A phase 2 study of SRT501 (resveratrol) with bortezomib for patients with relapsed and or refractory multiple myelomaRakesh Popat, Torben Plesner, Faith Davies, et al.
British Journal of Clinical Pharmacology|January 23, 2014
A phase II, randomized, placebo-controlled, double-blind, multi-dose study of SRT2104, a SIRT1 activator, in subjects with type 2 diabetesArun Baksi, Oleg Kraydashenko, Alsu Zalevkaya, et al.
Cancer Research|December 7, 2007
The novel combination of chlorpromazine and pentamidine exerts synergistic antiproliferative effects through dual mitotic actionMargaret S Lee, Lisa Johansen, Yanzhen Zhang, et al.
Pageof 7

Showing results (41-50 of 68) with videos related to

Sort By:
Pageof 7
Journal of Traumatic Stress|July 16, 2004
A concise measure of anger in combat-related posttraumatic stress disorderDavid Forbes, Graeme Hawthorne, Peter Elliott, et al.
Journal of Traumatic Stress|January 2, 2007
Is mixed-handedness a marker of treatment response in posttraumatic stress disorder?: a pilot studyDavid Forbes, Jessica Carty, Peter Elliott, et al.
European Journal of Preventive Cardiology|June 5, 2013
Red flags for persistent or worsening anxiety and depression after an acute cardiac event: a 6-month longitudinal study in regional and rural AustraliaBarbara Murphy, Deborah Ludeman, Peter Elliott, et al.
Journal of Cardiopulmonary Rehabilitation and Prevention|March 13, 2013
Predicting mortality 12 years after an acute cardiac event: comparison between inhospital and 2-month assessment of depressive symptoms in womenBarbara Murphy, Michelle Rogerson, Marian Worcester, et al.
British Journal of Clinical Pharmacology|May 24, 2012
Pharmacokinetics and tolerability of SRT2104, a first-in-class small molecule activator of SIRT1, after single and repeated oral administration in manEthan Hoffmann, Jeff Wald, Siva Lavu, et al.
Nano Letters|August 19, 2021
Spin/Valley Coupled Dynamics of Electrons and Holes at the MoS<sub>2</sub>-MoSe<sub>2</sub> InterfaceAbhijeet Kumar, Denis Yagodkin, Nele Stetzuhn, et al.
Journal of Affective Disorders|February 5, 2013
A trajectory-based approach to understand the factors associated with persistent depressive symptoms in primary careJane Gunn, Peter Elliott, Konstancja Densley, et al.
British Journal of Haematology|December 5, 2012
A phase 2 study of SRT501 (resveratrol) with bortezomib for patients with relapsed and or refractory multiple myelomaRakesh Popat, Torben Plesner, Faith Davies, et al.
British Journal of Clinical Pharmacology|January 23, 2014
A phase II, randomized, placebo-controlled, double-blind, multi-dose study of SRT2104, a SIRT1 activator, in subjects with type 2 diabetesArun Baksi, Oleg Kraydashenko, Alsu Zalevkaya, et al.
Cancer Research|December 7, 2007
The novel combination of chlorpromazine and pentamidine exerts synergistic antiproliferative effects through dual mitotic actionMargaret S Lee, Lisa Johansen, Yanzhen Zhang, et al.
Pageof 7